XML 41 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Insider Trading Arrangements - shares
 3 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Matthew Rabinowitz    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement

​

On December 3, 2024, Matthew Rabinowitz, adopted a Rule 10b5-1 Trading Plan that provides for the sale of 130,000 shares of our common stock pursuant to the terms of the plan between March 4, 2025 and August 23, 2025.

​

On September 13, 2024, Matthew Rabinowitz, our co-founder and executive chairman, adopted a trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that provided for the sale of 160,000 shares of our common stock pursuant to the terms of the plan between December 13, 2024 and May 14, 2025.
Name Matthew Rabinowitz Matthew Rabinowitz
Title co-founder and executive chairman co-founder and executive chairman
Rule 10b5-1 Arrangement Adopted true true
Adoption Date December 3, 2024 September 13, 2024
Aggregate Available 130,000 160,000
Steve Chapman    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement

​

On November 26, 2024, Solomon Moshkevich, our president, clinical diagnostics, adopted a Rule 10b5-1 Trading Plan that provides for the sale of up to 66,000 shares of our common stock pursuant to the terms of the plan between March 4, 2025 and November 30, 2026.

​

On December 2, 2024, Steve Chapman, our chief executive officer, amended a Rule 10b5-1 Trading Plan to provide for the potential sale of up to 395,452 shares of our common stock and the exercise of 156,825 stock options and sale of underlying shares of our common stock, pursuant to the terms of the plan between March 5, 2025 and November 30, 2026. A significant portion of the shares subject to the plan would not be sold unless the Company achieves specified performance targets.

 
Name Steve Chapman  
Title chief executive officer  
Aggregate Available 395,452  
Modification Date December 2, 2024  
Rule 10b5-1 Arrangement Modified true  
Jonathan Sheena    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement

​

On December 11, 2024, Jonathan Sheena, our co-founder and a member of our board of directors, adopted a Rule 10b5-1 Trading Plan that provides for the sale of 49,911 shares of our common stock pursuant to the terms of the plan between April 4, 2025 and April 29, 2026.

  
Name Jonathan Sheena  
Title co-founder and a member of our board of directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 11, 2024  
Aggregate Available 49,911  
Gail Marcus    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement

​

On December 11, 2024, Gail Marcus, a member of our board of directors, adopted a Rule 10b5-1 Trading Plan that provides for the sale of 6,618 shares of our common stock and the exercise of 16,299 stock options and sale of underlying shares of our common stock, pursuant to the terms of the plan between March 12, 2025 and December 31, 2025.

  
Name Gail Marcus  
Title member of our board of directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 11, 2024  
Solomon Moshkevich    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement

​

  
Name Solomon Moshkevich  
Title president  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 26, 2024  
Aggregate Available 66,000  
Sale of common stock arrangement | Gail Marcus    
Trading Arrangements, by Individual    
Aggregate Available 6,618  
Exercise of stock options arrangement | Steve Chapman    
Trading Arrangements, by Individual    
Aggregate Available 156,825  
Exercise of stock options arrangement | Gail Marcus    
Trading Arrangements, by Individual    
Aggregate Available 16,299